What Is the Role for TAVI in Failing Surgical Aortic Valves? A Review on Valve-in-Valve Interventions

Document Type

Article

Publication Date

8-1-2025

Publication Title

Catheterization and cardiovascular interventions

Abstract

Bioprosthetic surgical aortic valve failure represents a significant clinical challenge that necessitates timely and effective intervention to restore valve function and ensure patient well-being. Use of valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as a feasible alternative to reoperation surgical aortic valve replacement (SAVR). By providing a less invasive option, this approach offers the opportunity to reduce the potential risks of a reoperation surgery. However, it is important to note that implementing ViV-TAVI requires careful preparation. This review outlines a thorough approach to ViV-TAVI, encompassing preprocedural planning, valve selection, implantation procedure, and its complications. With the availability of updated clinical data supporting long-term outcomes, this particular strategy is an excellent choice for the treatment of failed surgical aortic bioprostheses.

Medical Subject Headings

Humans; Heart Valve Prosthesis; Transcatheter Aortic Valve Replacement; Bioprosthesis; Prosthesis Failure; Aortic Valve; Prosthesis Design; Risk Factors; Heart Valve Prosthesis Implantation; Aortic Valve Stenosis; Treatment Outcome; Reoperation; Patient Selection

PubMed ID

40537958

ePublication

ePub ahead of print

Volume

106

Issue

2

First Page

1383

Last Page

1400

Share

COinS